Aminoglycosides for the treatment of gram-negative infections: therapeutic use, resistance and future outlook

This publication has 30 references indexed in Scilit:

• The Most Frequent Aminoglycoside Resistance Mechanisms--Changes with Time and Geographic Area: A Reflection of Aminoglycoside Usage Patterns?
  Clinical Infectious Diseases, 1997
• Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
  Antimicrobial Agents and Chemotherapy, 1994
• Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy
  Antimicrobial Agents and Chemotherapy, 1992
• Factors Influencing Prognosis in Bacteremia Due to Gram-Negative Organisms: Evaluation of 448 Episodes in a Turkish University Hospital
  Clinical Infectious Diseases, 1992
• Comparison of the bactericidal activity of ciprofloxacin alone and in combination with selected antipseudomonal β-lactam agents against clinical isolates of Pseudomonas aeruginosa
  Diagnostic Microbiology and Infectious Disease, 1988
• Emergence of Resistance during β-Lactam Therapy of Gram-Negative Infections
  Drugs, 1988
• Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with Granulocytopenia
  New England Journal of Medicine, 1987
• Development of resistance during antibiotic therapy
  European Journal of Clinical Microbiology & Infectious Diseases, 1987
• Significance of antimicrobial synergism for the outcome of gram negative sepsis
  The Lancet Healthy Longevity, 1977
• Synergistic Activity of Carbenicillin and Gentamicin in Experimental Pseudomonas Bacteremia in Neutropenic Rats
  Antimicrobial Agents and Chemotherapy, 1976